These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27803756)

  • 1. Dasatinib-induced pleural effusion: Chylothorax, an option to consider.
    Ferreiro L; San-José E; Suárez-Antelo J; Valdés L
    Ann Thorac Med; 2016; 11(4):289-293. PubMed ID: 27803756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
    McCormack PL; Keam SJ
    BioDrugs; 2012 Feb; 26(1):61-4. PubMed ID: 22233429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib-induced chylothorax: report of a case and review of the literature.
    Chen B; Wu Z; Wang Q; Li W; Cheng D
    Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review.
    Liu Q; Fu J; Zhang A
    Transl Cancer Res; 2023 Jan; 12(1):194-200. PubMed ID: 36760377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
    Hsu CC; Hsu JF; Wu KL
    Respirol Case Rep; 2021 Jun; 9(6):e00753. PubMed ID: 33976882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
    Kaiafa G; Kakaletsis N; Savopoulos C; Perifanis V; Giannouli A; Papadopoulos N; Zisekas S; Hatzitolios AI
    J Clin Pharm Ther; 2014 Feb; 39(1):102-5. PubMed ID: 24188312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
    Yang L; Lu N; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].
    Zhu Y; Pan LQ; Qian SX; Song P; Yu H; Zhang SJ; Ge Z; Hong M; Tian T; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):581-6. PubMed ID: 23815902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural effusions due to dasatinib.
    Brixey AG; Light RW
    Curr Opin Pulm Med; 2010 Jul; 16(4):351-6. PubMed ID: 20375898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
    Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
    Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Keam SJ
    BioDrugs; 2008; 22(1):59-69. PubMed ID: 18215092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
    Gore L; Kearns PR; de Martino ML; Lee ; De Souza CA; Bertrand Y; Hijiya N; Stork LC; Chung NG; Cardos RC; Saikia T; Fagioli F; Seo JJ; Landman-Parker J; Lancaster D; Place AE; Rabin KR; Sacchi M; Swanink R; Zwaan CM
    J Clin Oncol; 2018 May; 36(13):1330-1338. PubMed ID: 29498925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature review.
    Paul T; Ellahie AY; Almohtasib YS; Sinha U; El Omri H
    EJHaem; 2021 Aug; 2(3):545-550. PubMed ID: 35844702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib.
    Bradt N; Olbrechts F; Alexander P; Salembier A
    Eur J Case Rep Intern Med; 2022; 9(10):003601. PubMed ID: 36415836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
    Hagihara M; Iriyama N; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
    Oncol Rep; 2016 Nov; 36(5):2976-2982. PubMed ID: 27665844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.
    Eskazan AE; Eyice D; Kurt EA; Elverdi T; Yalniz FF; Salihoglu A; Ar MC; Ongoren Aydin S; Baslar Z; Ferhanoglu B; Aydin Y; Tuzuner N; Ozbek U; Soysal T
    Leuk Res; 2014 Jul; 38(7):781-7. PubMed ID: 24832371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib: an anti-tumour agent via Src inhibition.
    Gnoni A; Marech I; Silvestris N; Vacca A; Lorusso V
    Curr Drug Targets; 2011 Apr; 12(4):563-78. PubMed ID: 21226671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia.
    Makimoto G; Misawa M; Maeda Y; Kiura K
    Respir Med Case Rep; 2022; 37():101662. PubMed ID: 35585905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
    Lilly MB; Ottmann OG; Shah NP; Larson RA; Reiffers JJ; Ehninger G; Müller MC; Charbonnier A; Bullorsky E; Dombret H; Brigid Bradley-Garelik M; Zhu C; Martinelli G
    Am J Hematol; 2010 Mar; 85(3):164-70. PubMed ID: 20131302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.